Lung Cancer Screening Market Scope And Analysis

  • Report Code : TIPRE00029996
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 188
Buy Now

Lung Cancer Screening Market Growth and Scope - 2031

Buy Now

Lung Cancer Screening Market Report Lung Cancer Screening Market Size and Share Lung Cancer Screening Market Scope and Analysis

Lung Cancer Screening Market Report Scope

Report Attribute Details
Market size in 2022 US$ 2.33 Billion
Market Size by 2030 US$ 4.36 Billion
Global CAGR (2022 - 2030) 8.2%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Cancer Type
  • Non-Small Cell Lung Cancer
By Technology
  • Low-Dose Computed Tomography
  • Chest X-Ray
  • Liquid Biopsy
By Age Group
  • 50 & Older and Below 50
By End User
  • Hospitals
  • Diagnostic Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Intelerad Medical Systems Incorporated
  • Nuance Communications Inc
  • GE HealthCare Technologies Inc
  • Medtronic Plc
  • Canon Medical Systems Corp
  • Koninklijke Philips NV
  • Siemens AG
  • CVS Health
  • bioAffinity Technologies Inc